Abstract | AIMS: METHODS AND RESULTS: By in vivo experiments, we showed for the first time female bone marrow-derived mesenchymal stem cells possessed a better therapeutic potential against monocrotaline-induced pulmonary arterial hypertension in C57BL/6J mice compared with male counterparts. In vitro experiments demonstrated superior function of female bone marrow-derived mesenchymal stem cells in cell proliferation, migration and [Ca(2+)]i kinetics. Moreover, we unexpectedly found that, compared with male ones, female bone marrow-derived mesenchymal stem cells had a higher expression level of glyceraldehyde-3-phosphate dehydrogenase and manipulations of its expression in female or male bone marrow-derived mesenchymal stem cells profoundly affected their cellular behaviours and therapeutic efficacies against pulmonary arterial hypertension. CONCLUSION:
|
Authors | Rubin Tan, Jiansha Li, Xiaochun Peng, Liping Zhu, Lei Cai, Tao Wang, Yuan Su, Kaikobad Irani, Qinghua Hu |
Journal | Cardiovascular research
(Cardiovasc Res)
Vol. 100
Issue 1
Pg. 19-27
(Oct 01 2013)
ISSN: 1755-3245 [Electronic] England |
PMID | 23801767
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)
- Calcium
|
Topics |
- Animals
- Bone Marrow Cells
(enzymology)
- Calcium
(metabolism)
- Cells, Cultured
- Familial Primary Pulmonary Hypertension
- Female
- Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)
(physiology)
- Hypertension, Pulmonary
(therapy)
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells
(physiology)
- Mice
- Mice, Inbred C57BL
- Sex Characteristics
|